| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041422711 |
| P356 | DOI | 10.1186/1745-6150-9-21 |
| P932 | PMC publication ID | 4218944 |
| P698 | PubMed publication ID | 25351961 |
| P5875 | ResearchGate publication ID | 267744907 |
| P50 | author | Paulo Anastácio Furtado Pacheco | Q86420148 |
| P2093 | author name string | Izabel C N P Paixão | |
| Leonardo G B Ferreira | |||
| Robson X Faria | |||
| P2860 | cites work | High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR | Q22242246 |
| P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels | Q24533248 | ||
| Pathogenesis of human immunodeficiency virus infection | Q24634681 | ||
| Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | Q24651475 | ||
| Cytopathic Mechanisms of HIV-1 | Q27485043 | ||
| Molecular physiology of P2X receptors | Q28203477 | ||
| International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 | ||
| Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation | Q28216646 | ||
| The birth and postnatal development of purinergic signalling | Q28277866 | ||
| Pharmacological profiles of cloned mammalian P2Y-receptor subtypes | Q28279497 | ||
| Receptors for purines and pyrimidines | Q28283941 | ||
| Signaling at purinergic P2X receptors | Q28296741 | ||
| New therapeutic approaches targeted at the late stages of the HIV-1 replication cycle | Q28299282 | ||
| A role for mitogen-activated protein kinase(Erk1/2) activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death | Q28513626 | ||
| ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion | Q28587109 | ||
| ATP-induced apoptosis of thymocytes is mediated by activation of P2 X 7 receptor and involves de novo ceramide synthesis and mitochondria | Q28594653 | ||
| HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes | Q81606331 | ||
| Dysregulation of the inflammatory response to the parasite, Toxoplasma gondii, in P2X7 receptor-deficient mice | Q82280464 | ||
| Experimental and modeling studies of desensitization of P2X3 receptors | Q83181541 | ||
| Purinergic P2X7 receptor drives T cell lineage choice and shapes peripheral γδ cells | Q84254030 | ||
| Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture | Q39439722 | ||
| Is there a basis for distinguishing two types of P2-purinoceptor? | Q39497248 | ||
| Adenosine 5'-triphosphate is the predominant source of peripheral adenosine in human B lymphoblasts | Q39660085 | ||
| Monoclonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells. | Q39664323 | ||
| Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans | Q39823787 | ||
| Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages | Q40017700 | ||
| A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages | Q40355682 | ||
| Use-dependent inhibition of P2X3 receptors by nanomolar agonist. | Q40386589 | ||
| G protein-coupled P2 purinoceptors: from molecular biology to functional responses | Q40443944 | ||
| Are second messengers crucial for opening the pore associated with P2X7 receptor? | Q40506943 | ||
| Purinoceptors: are there families of P2X and P2Y purinoceptors? | Q40510363 | ||
| Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase | Q40518676 | ||
| Suramin inhibits the in vitro expression of encephalitis B virus proteins NS3 and E. | Q40579665 | ||
| Secretion of IL-2 and IFN-gamma, but not IL-4, by antigen-specific T cells requires extracellular ATP. | Q40665495 | ||
| Benchmarks for antiretroviral therapy | Q40716736 | ||
| Purinergic signalling in the immune system. A brief update | Q40730116 | ||
| Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation | Q40813156 | ||
| The inhibition of yellow fever virus multiplication by suramin: a preliminary note. | Q40847027 | ||
| Pore dilation of neuronal P2X receptor channels | Q40960421 | ||
| The transmitter-gated channels: a range of receptor types and structures | Q41182186 | ||
| Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors | Q41203738 | ||
| Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus | Q41254783 | ||
| Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. | Q41361630 | ||
| Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. | Q41646184 | ||
| Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin | Q41867941 | ||
| Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons | Q42069973 | ||
| Regulation of innate immunity by extracellular nucleotides | Q42252932 | ||
| Autocrine Purinergic Receptor Signaling Is Essential for Macrophage Chemotaxis | Q42955253 | ||
| Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages | Q43125007 | ||
| Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. | Q43540455 | ||
| P2 receptors meet the immune system | Q43549240 | ||
| The P2X7 purinergic receptor on bovine macrophages mediates mycobacterial death | Q43568198 | ||
| ATP-mediated killing of Mycobacterium bovis bacille Calmette-Guérin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. | Q43600947 | ||
| Detection of P2X purinergic receptors on human B lymphocytes | Q43632714 | ||
| ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion | Q43729132 | ||
| P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. | Q43846494 | ||
| ATP-induced activation of human B lymphocytes via P2-purinoceptors | Q43923854 | ||
| Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals | Q44072580 | ||
| Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. | Q44079521 | ||
| Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils | Q44094639 | ||
| Infection with Leishmania amazonensis upregulates purinergic receptor expression and induces host-cell susceptibility to UTP-mediated apoptosis. | Q44545044 | ||
| A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. | Q44649133 | ||
| P2X7 receptor inhibition improves recovery after spinal cord injury | Q44982503 | ||
| Effects of extracellular ATP and adenosine on different thymocyte subsets: possible role of ATP-gated channels and G protein-coupled purinergic receptor | Q44982696 | ||
| Infection of human endothelium in vitro by cytomegalovirus causes enhanced expression of purinergic receptors: a potential virus escape mechanism? | Q45398925 | ||
| ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. | Q45930388 | ||
| Hypertonic stress regulates T-cell function by the opposing actions of extracellular adenosine triphosphate and adenosine | Q46217744 | ||
| Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. | Q46338518 | ||
| ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. | Q51887546 | ||
| New developments in anti-HIV chemotherapy | Q56786460 | ||
| Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors | Q57731080 | ||
| Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7ATP Receptor | Q61764030 | ||
| An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes | Q70884431 | ||
| Effect of adenosine on the expression of beta(2) integrins and L-selectin of human polymorphonuclear leukocytes in vitro | Q71131920 | ||
| The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis | Q71535990 | ||
| Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes | Q72037525 | ||
| Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor | Q73017061 | ||
| P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production | Q73303433 | ||
| Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease | Q73470103 | ||
| Apoptosis of murine thymocytes induced by extracellular ATP is dose- and cytosolic pH-dependent | Q73733767 | ||
| ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors | Q73767661 | ||
| Pharmacologic properties of P(2Z)/P2X(7 )receptor characterized in murine dendritic cells: role on the induction of apoptosis | Q74055077 | ||
| ATP-evoked Ca2+ transients and currents in murine thymocytes: possible role for P2X receptors in death by neglect | Q77844730 | ||
| Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis | Q79224117 | ||
| A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis | Q79344934 | ||
| Long-Term suppression of HIV infection: benefits and limitations of current treatment options | Q79715938 | ||
| P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signaling pathways | Q80142412 | ||
| Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase | Q80564159 | ||
| A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells | Q80797764 | ||
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | Q34701303 | ||
| HIV-1 replication | Q35016623 | ||
| Activation and regulation of purinergic P2X receptor channels | Q35122793 | ||
| Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection | Q35208371 | ||
| Viral determinants of HIV-1 macrophage tropism | Q35593158 | ||
| Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation | Q35606616 | ||
| Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs | Q35832040 | ||
| The multifactorial nature of HIV-1 latency | Q35935335 | ||
| Cellular distribution and functions of P2 receptor subtypes in different systems | Q35952737 | ||
| ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation | Q36232232 | ||
| Dynamics of ATP-induced calcium signaling in single mouse thymocytes | Q36263603 | ||
| Activation and Desensitization of the Recombinant P2X1 Receptor at Nanomolar ATP Concentrations | Q36412485 | ||
| The P2X7 receptor: a key player in IL-1 processing and release | Q36425273 | ||
| Purinergic receptors are required for HIV-1 infection of primary human macrophages | Q36429974 | ||
| P2 receptors: intracellular signaling | Q36439708 | ||
| P2 receptors and immunity. | Q36446067 | ||
| Signal Transduction by P2-Purinergic Receptors for Extracellular ATP | Q36640253 | ||
| Purine and pyrimidine receptors | Q36765468 | ||
| Dissecting the HIV-specific immune response: a systems biology approach | Q36769115 | ||
| ATP-gated P2X cation-channels | Q37227700 | ||
| Autocrine regulation of T-cell activation by ATP release and P2X7 receptors | Q37283804 | ||
| Adenosine: an endogenous modulator of innate immune system with therapeutic potential | Q37493077 | ||
| Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs | Q37615893 | ||
| Ligand-gated purinergic receptors regulate HIV-1 Tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures | Q37646749 | ||
| Purinergic signaling: a novel mechanism in immune surveillance | Q37728015 | ||
| Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection | Q37852942 | ||
| Modulation of P2X(7) purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination. | Q37855027 | ||
| Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice | Q37859112 | ||
| Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. | Q37868590 | ||
| Regulation of leukocyte function by adenosine receptors | Q37876538 | ||
| New approaches for antiviral targeting of HIV assembly | Q37901613 | ||
| Dynamics of innate immunity are key to chronic immune activation in AIDS. | Q37966761 | ||
| Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future | Q37975129 | ||
| The sixth sense: hematopoietic stem cells detect danger through purinergic signaling | Q38025606 | ||
| P2X7 receptor regulation of non-classical secretion from immune effector cells | Q38033709 | ||
| P2X7 receptors: channels, pores and more | Q38042107 | ||
| Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 | ||
| Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis | Q30432676 | ||
| Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance | Q30436506 | ||
| Modulation of P2Z/P2X(7) receptor activity in macrophages infected with Chlamydia psittaci. | Q31715200 | ||
| Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines. | Q33257485 | ||
| ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages | Q33351778 | ||
| IL-1beta processing in host defense: beyond the inflammasomes | Q33535878 | ||
| Dynamic selectivity filters in ion channels | Q33731015 | ||
| Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus | Q33781062 | ||
| Extracellular ATP in T-lymphocyte activation: possible role in effector functions | Q33860736 | ||
| Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis | Q34012277 | ||
| Extracellular ATP in the immune system: more than just a "danger signal". | Q34015956 | ||
| Basal release of ATP: an autocrine-paracrine mechanism for cell regulation | Q34020834 | ||
| Immune cell regulation by autocrine purinergic signalling | Q34025783 | ||
| Cellular function and molecular structure of ecto-nucleotidases. | Q34031794 | ||
| Differential modulation of ATP-induced P2X7-associated permeabilities to cations and anions of macrophages by infection with Leishmania amazonensis. | Q34038262 | ||
| P2Y nucleotide receptors: promise of therapeutic applications | Q34062142 | ||
| Host factors and the pathogenesis of HIV-induced disease | Q34063826 | ||
| The role of the P2X₇ receptor in infectious diseases | Q34079146 | ||
| P2 purinergic receptors: modulation of cell function and therapeutic potential | Q34084722 | ||
| P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. | Q34097191 | ||
| Molecular pharmacology of P2Y-receptors | Q34101812 | ||
| Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse | Q34128014 | ||
| Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. | Q34140085 | ||
| Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation | Q34143696 | ||
| Molecular physiology of P2X receptors and ATP signalling at synapses | Q34188163 | ||
| The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively | Q34248005 | ||
| P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection | Q34261784 | ||
| P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release | Q34267097 | ||
| Nomenclature and classification of purinoceptors. | Q34324355 | ||
| Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection | Q34355690 | ||
| Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors | Q34378750 | ||
| Nucleotide signalling during inflammation | Q34464511 | ||
| P304 | page(s) | 21 | |
| P577 | publication date | 2014-10-29 | |
| P1433 | published in | Biology Direct | Q1954915 |
| P1476 | title | Putative roles of purinergic signaling in human immunodeficiency virus-1 infection | |
| P478 | volume | 9 |
| Q98578557 | Ca2+ -dependent release of ATP from astrocytes affects herpes simplex virus Type 1 infection of neurons |
| Q90191907 | Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion |
| Q26774666 | Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation |
| Q42367885 | Purinergic Signalling: Therapeutic Developments |
| Q89037287 | Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets? |
Search more.